[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$607b](/topic/$607b) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$SYK In 3Q25 the benefits of Strykers diversified business model were abundantly and positively apparent. Sales at $6.07B up XXX% Y/Y organically surpassed Consensus $6.03B despite a softer-than-anticipated MedSurg & Neurotechnology (63% of total sales) performance. Up XXXX% Y/Y organically Orthopaedics sales at $2.25B powered the better-than-expected top-line performance vs. Consensus estimates. Underpinned by healthy procedure volumes continued recent product launch uptake and another record US/OUS MAKO installation quarter we were encouraged by the robust Orthopaedics performance both in a" [X Link](https://x.com/BottomUpEquity/status/1984189898325168303) [@BottomUpEquity](/creator/x/BottomUpEquity) 2025-10-31T09:25Z XXX followers, XXX engagements "🚨 $MO Altria Group Inc. earnings results 💥 EPS: $XXXX vs. $XXXX est. (+0.69%) ✅ Revenue: $6.07B vs. $5.29B est. (+14.72%) ✅ #Earnings #StockMarket" [X Link](https://x.com/ScpFundamental/status/1983931783969128860) [@ScpFundamental](/creator/x/ScpFundamental) 2025-10-30T16:19Z XXX followers, XX engagements "Altria $MO Q3-25. Results: 📊 Adj. EPS: $XXXX 🟢 💰 Revenue: $6.07B 🟢 📈 Net Income: $2.38B 🔎 Altria expanded its $1B share repurchase program to $2B and raised the lower end of FY25 EPS guidance amid resilient core tobacco performance and continued investment in smoke-free products" [X Link](https://x.com/marketsday/status/1983876967083733369) [@marketsday](/creator/x/marketsday) 2025-10-30T12:41Z 19.8K followers, XXX engagements "Altria Group $MO Reports Earnings: Revenue: $6.07B est. $5.31B ✅ EPS: $XXXX est. $XXXX ✅ Shares are down X% pre market" [X Link](https://x.com/DividendTalks/status/1983854333054873949) [@DividendTalks](/creator/x/DividendTalks) 2025-10-30T11:11Z 60.6K followers, 4004 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SYK In 3Q25 the benefits of Strykers diversified business model were abundantly and positively apparent. Sales at $6.07B up XXX% Y/Y organically surpassed Consensus $6.03B despite a softer-than-anticipated MedSurg & Neurotechnology (63% of total sales) performance. Up XXXX% Y/Y organically Orthopaedics sales at $2.25B powered the better-than-expected top-line performance vs. Consensus estimates. Underpinned by healthy procedure volumes continued recent product launch uptake and another record US/OUS MAKO installation quarter we were encouraged by the robust Orthopaedics performance both in a"
X Link @BottomUpEquity 2025-10-31T09:25Z XXX followers, XXX engagements
"🚨 $MO Altria Group Inc. earnings results 💥 EPS: $XXXX vs. $XXXX est. (+0.69%) ✅ Revenue: $6.07B vs. $5.29B est. (+14.72%) ✅ #Earnings #StockMarket"
X Link @ScpFundamental 2025-10-30T16:19Z XXX followers, XX engagements
"Altria $MO Q3-25. Results: 📊 Adj. EPS: $XXXX 🟢 💰 Revenue: $6.07B 🟢 📈 Net Income: $2.38B 🔎 Altria expanded its $1B share repurchase program to $2B and raised the lower end of FY25 EPS guidance amid resilient core tobacco performance and continued investment in smoke-free products"
X Link @marketsday 2025-10-30T12:41Z 19.8K followers, XXX engagements
"Altria Group $MO Reports Earnings: Revenue: $6.07B est. $5.31B ✅ EPS: $XXXX est. $XXXX ✅ Shares are down X% pre market"
X Link @DividendTalks 2025-10-30T11:11Z 60.6K followers, 4004 engagements
/topic/$607b/posts